Kymera Therapeutics vs Maze Therapeutics
KYMR and MAZE side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How KYMR and MAZE compare
Kymera Therapeutics is the larger company, worth 6.0 times as much as Maze Therapeutics ($10.5B against $1.7B).
Kymera Therapeutics scores higher on the StockData Score (9 against 4 for Maze Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | KYMR | MAZE |
|---|---|---|
| Size and price | ||
| Market cap | $10.5B | $1.7B |
| Share price | $126.63 | $31.48 |
| Change, 1 year | 111% | 0.70% |
| Change, 5 years | 95.0% | – |
| Beta (5Y) | 1.97 | 0.96 |
| Employees | 238 | 141 |
| StockData Score | ||
| Total score | 9 (better) | 4 |
| Valuation score | 0 | 0 |
| Growth score | 1 (better) | 0 |
| Performance score | 2 (better) | 1 |
| Health score | 6 (better) | 3 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 103× | – |
| P/B | 6.5× | 3.9× (better) |
| FCF yield | −2.7% (better) | −6.1% |
| Fair value | $38.85 | – |
| Margin of safety | −226% | – |
| Growth | ||
| Revenue growth (TTM) | 134% | – |
| Revenue growth, 5Y average | 2.9% | – |
| Profitability | ||
| Gross margin | 0.00% | – |
| Operating margin | −396% | – |
| Net margin | −342% | – |
| FCF margin | −283% | – |
| Return on equity | −27.3% (better) | −37.3% |
| Return on invested capital | −59.0% (better) | −292% |
| Financial health | ||
| Debt / equity | 0.00 | 0.09 (better) |
| Current ratio | 11.13 | 18.31 (better) |
| Altman Z-score | 40.23 (better) | 11.89 |
| Piotroski F-score | 4 (better) | 3 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 117% | 105% |
| Held by insiders | 39.4% | 16.9% |
| Insider net buying, 12 months | −$297M | −$22.1M (better) |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 19.7% | 14.2% |
Go deeper
- KYMR stock overview
- KYMR income statement
- KYMR valuation and score
- MAZE stock overview
- MAZE income statement
- MAZE valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.